tsk gel pwh guard column Search Results


86
Tosoh Corporation tsk gel pwh guard column
Tsk Gel Pwh Guard Column, supplied by Tosoh Corporation, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tsk+gel+pwh+guard+column/column+guard/10__1016_slash_j__lwt__2025__118239-87-4-15
Average 86 stars, based on 1 article reviews
tsk gel pwh guard column - by Bioz Stars, 2026-08
86/100 stars
  Buy from Supplier

90
Siemens AG siemens immulite autoanalyzer
Siemens Immulite Autoanalyzer, supplied by Siemens AG, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tsk+gel+pwh+guard+column/immulite+2000/pm36818436-61-8-8
Average 90 stars, based on 1 article reviews
siemens immulite autoanalyzer - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
CH Instruments chi-square test
Sociodemographic, lifestyle, clinical, and <t> HIV-related </t> characteristics of study participants
Chi Square Test, supplied by CH Instruments, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tsk+gel+pwh+guard+column/chi+square+test/pmc08361343-117-11-19
Average 90 stars, based on 1 article reviews
chi-square test - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

86
Osaka Organic Chemical Industry Ltd pwh
Outreach Efforts in ACCELERATE Flowchart from Prescreening <t>of</t> <t>OOC</t> <t>PWH</t> until Study Enrollment. Unreachable: PWH who could not be contacted after sharing study flyer, 4 phone call across 3 weeks, a patient portal message and an email. Out of State: Moved outside Missouri, one of the exclusion criteria of ACCELERATE. Unable to Consent: People who cannot understand and sign the informed consent. Study Drug: Bictegravir/Emtricitabine/Tenofovir Alafenamide
Pwh, supplied by Osaka Organic Chemical Industry Ltd, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tsk+gel+pwh+guard+column/pwh/pmc12793536-22-4-8
Average 86 stars, based on 1 article reviews
pwh - by Bioz Stars, 2026-08
86/100 stars
  Buy from Supplier

86
Wolters Kluwer Health pwh
Outreach Efforts in ACCELERATE Flowchart from Prescreening <t>of</t> <t>OOC</t> <t>PWH</t> until Study Enrollment. Unreachable: PWH who could not be contacted after sharing study flyer, 4 phone call across 3 weeks, a patient portal message and an email. Out of State: Moved outside Missouri, one of the exclusion criteria of ACCELERATE. Unable to Consent: People who cannot understand and sign the informed consent. Study Drug: Bictegravir/Emtricitabine/Tenofovir Alafenamide
Pwh, supplied by Wolters Kluwer Health, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tsk+gel+pwh+guard+column/pwh/10__1097_slash_qad__0000000000003410-99-8-20
Average 86 stars, based on 1 article reviews
pwh - by Bioz Stars, 2026-08
86/100 stars
  Buy from Supplier

90
Factor Therapeutics non-factor therapeutics
Outreach Efforts in ACCELERATE Flowchart from Prescreening <t>of</t> <t>OOC</t> <t>PWH</t> until Study Enrollment. Unreachable: PWH who could not be contacted after sharing study flyer, 4 phone call across 3 weeks, a patient portal message and an email. Out of State: Moved outside Missouri, one of the exclusion criteria of ACCELERATE. Unable to Consent: People who cannot understand and sign the informed consent. Study Drug: Bictegravir/Emtricitabine/Tenofovir Alafenamide
Non Factor Therapeutics, supplied by Factor Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tsk+gel+pwh+guard+column/non+factor+therapeutics/pm36920862-59-9-2
Average 90 stars, based on 1 article reviews
non-factor therapeutics - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
HighRes Biosolutions 1h hard pulse
Outreach Efforts in ACCELERATE Flowchart from Prescreening <t>of</t> <t>OOC</t> <t>PWH</t> until Study Enrollment. Unreachable: PWH who could not be contacted after sharing study flyer, 4 phone call across 3 weeks, a patient portal message and an email. Out of State: Moved outside Missouri, one of the exclusion criteria of ACCELERATE. Unable to Consent: People who cannot understand and sign the informed consent. Study Drug: Bictegravir/Emtricitabine/Tenofovir Alafenamide
1h Hard Pulse, supplied by HighRes Biosolutions, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tsk+gel+pwh+guard+column/1h+hard+pulse/pmc06875545__10858_2019_287_MOESM1_ESM-328-33-20
Average 90 stars, based on 1 article reviews
1h hard pulse - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Johns Hopkins HealthCare pwh
Outreach Efforts in ACCELERATE Flowchart from Prescreening <t>of</t> <t>OOC</t> <t>PWH</t> until Study Enrollment. Unreachable: PWH who could not be contacted after sharing study flyer, 4 phone call across 3 weeks, a patient portal message and an email. Out of State: Moved outside Missouri, one of the exclusion criteria of ACCELERATE. Unable to Consent: People who cannot understand and sign the informed consent. Study Drug: Bictegravir/Emtricitabine/Tenofovir Alafenamide
Pwh, supplied by Johns Hopkins HealthCare, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tsk+gel+pwh+guard+column/pwh/pmc11778455-5-2-5
Average 90 stars, based on 1 article reviews
pwh - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Medical Scientific and Chemicals Inc eligible pwh
Outreach Efforts in ACCELERATE Flowchart from Prescreening <t>of</t> <t>OOC</t> <t>PWH</t> until Study Enrollment. Unreachable: PWH who could not be contacted after sharing study flyer, 4 phone call across 3 weeks, a patient portal message and an email. Out of State: Moved outside Missouri, one of the exclusion criteria of ACCELERATE. Unable to Consent: People who cannot understand and sign the informed consent. Study Drug: Bictegravir/Emtricitabine/Tenofovir Alafenamide
Eligible Pwh, supplied by Medical Scientific and Chemicals Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tsk+gel+pwh+guard+column/eligible+pwh/pmc09462952-161-2-25
Average 90 stars, based on 1 article reviews
eligible pwh - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

86
Tosoh Corporation tskgel g3000 guardcolumn pwh
Outreach Efforts in ACCELERATE Flowchart from Prescreening <t>of</t> <t>OOC</t> <t>PWH</t> until Study Enrollment. Unreachable: PWH who could not be contacted after sharing study flyer, 4 phone call across 3 weeks, a patient portal message and an email. Out of State: Moved outside Missouri, one of the exclusion criteria of ACCELERATE. Unable to Consent: People who cannot understand and sign the informed consent. Study Drug: Bictegravir/Emtricitabine/Tenofovir Alafenamide
Tskgel G3000 Guardcolumn Pwh, supplied by Tosoh Corporation, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tsk+gel+pwh+guard+column/column+g3000swxl+tskgel/pmc12539426-105-18-23
Average 86 stars, based on 1 article reviews
tskgel g3000 guardcolumn pwh - by Bioz Stars, 2026-08
86/100 stars
  Buy from Supplier

90
ProMIS Neurosciences promis-29
Outreach Efforts in ACCELERATE Flowchart from Prescreening <t>of</t> <t>OOC</t> <t>PWH</t> until Study Enrollment. Unreachable: PWH who could not be contacted after sharing study flyer, 4 phone call across 3 weeks, a patient portal message and an email. Out of State: Moved outside Missouri, one of the exclusion criteria of ACCELERATE. Unable to Consent: People who cannot understand and sign the informed consent. Study Drug: Bictegravir/Emtricitabine/Tenofovir Alafenamide
Promis 29, supplied by ProMIS Neurosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tsk+gel+pwh+guard+column/promis+29/pm34888899-74-9-1
Average 90 stars, based on 1 article reviews
promis-29 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Aelix Therapeutics aelix-0023
Outreach Efforts in ACCELERATE Flowchart from Prescreening <t>of</t> <t>OOC</t> <t>PWH</t> until Study Enrollment. Unreachable: PWH who could not be contacted after sharing study flyer, 4 phone call across 3 weeks, a patient portal message and an email. Out of State: Moved outside Missouri, one of the exclusion criteria of ACCELERATE. Unable to Consent: People who cannot understand and sign the informed consent. Study Drug: Bictegravir/Emtricitabine/Tenofovir Alafenamide
Aelix 0023, supplied by Aelix Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tsk+gel+pwh+guard+column/aelix+002/pm40038256-166-16-8
Average 90 stars, based on 1 article reviews
aelix-0023 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

Image Search Results


Sociodemographic, lifestyle, clinical, and  HIV-related  characteristics of study participants

Journal: Sleep

Article Title: Sleep health and cognitive function among people with and without HIV: the use of different machine learning approaches

doi: 10.1093/sleep/zsab035

Figure Lengend Snippet: Sociodemographic, lifestyle, clinical, and HIV-related characteristics of study participants

Article Snippet: Comparisons of sociodemographic, lifestyle, and clinical characteristics across older PWH, younger PWH, and HIV-negative individuals were carried out using chi-square test, Fisher’s exact test, and Wilcoxon rank‐sum tests as appropriate.

Techniques: Injection, Biomarker Discovery

Association of average sleep duration, WASO, and maintenance efficiency with the global cognitive T-score, as estimated via rank regression, adjusting for age, gender, ethnicity, education, and ongoing use of sleep medication

Journal: Sleep

Article Title: Sleep health and cognitive function among people with and without HIV: the use of different machine learning approaches

doi: 10.1093/sleep/zsab035

Figure Lengend Snippet: Association of average sleep duration, WASO, and maintenance efficiency with the global cognitive T-score, as estimated via rank regression, adjusting for age, gender, ethnicity, education, and ongoing use of sleep medication

Article Snippet: Comparisons of sociodemographic, lifestyle, and clinical characteristics across older PWH, younger PWH, and HIV-negative individuals were carried out using chi-square test, Fisher’s exact test, and Wilcoxon rank‐sum tests as appropriate.

Techniques:

VIP and VIM for each actigraphy variable as obtained from PLS and random forest, respectively, run separately in PWH ( n = 344) and HIV-negative individuals ( n = 119). Note : VIM is expressed as the percentage relative to that of the variable with the highest VIM. The random forest model additionally included age, gender, ethnicity, education, and use of sleep medication; VIM for all variables, including potential confounders, are shown in .

Journal: Sleep

Article Title: Sleep health and cognitive function among people with and without HIV: the use of different machine learning approaches

doi: 10.1093/sleep/zsab035

Figure Lengend Snippet: VIP and VIM for each actigraphy variable as obtained from PLS and random forest, respectively, run separately in PWH ( n = 344) and HIV-negative individuals ( n = 119). Note : VIM is expressed as the percentage relative to that of the variable with the highest VIM. The random forest model additionally included age, gender, ethnicity, education, and use of sleep medication; VIM for all variables, including potential confounders, are shown in .

Article Snippet: Comparisons of sociodemographic, lifestyle, and clinical characteristics across older PWH, younger PWH, and HIV-negative individuals were carried out using chi-square test, Fisher’s exact test, and Wilcoxon rank‐sum tests as appropriate.

Techniques:

Association between RU SATED sleep dimensions and global cognitive T-score in PWH ( n = 344) and HIV-negative individuals ( n = 119). Associations are expressed as differences in the median global T-scores with participants reporting “good” sleep health as a reference category and adjusting for potential confounders.

Journal: Sleep

Article Title: Sleep health and cognitive function among people with and without HIV: the use of different machine learning approaches

doi: 10.1093/sleep/zsab035

Figure Lengend Snippet: Association between RU SATED sleep dimensions and global cognitive T-score in PWH ( n = 344) and HIV-negative individuals ( n = 119). Associations are expressed as differences in the median global T-scores with participants reporting “good” sleep health as a reference category and adjusting for potential confounders.

Article Snippet: Comparisons of sociodemographic, lifestyle, and clinical characteristics across older PWH, younger PWH, and HIV-negative individuals were carried out using chi-square test, Fisher’s exact test, and Wilcoxon rank‐sum tests as appropriate.

Techniques:

Means (95% CI) of the 22 sleep variables (centered and scaled to unit variance) in PWH and HIV-negative individuals, stratified by groups identified using LCA.

Journal: Sleep

Article Title: Sleep health and cognitive function among people with and without HIV: the use of different machine learning approaches

doi: 10.1093/sleep/zsab035

Figure Lengend Snippet: Means (95% CI) of the 22 sleep variables (centered and scaled to unit variance) in PWH and HIV-negative individuals, stratified by groups identified using LCA.

Article Snippet: Comparisons of sociodemographic, lifestyle, and clinical characteristics across older PWH, younger PWH, and HIV-negative individuals were carried out using chi-square test, Fisher’s exact test, and Wilcoxon rank‐sum tests as appropriate.

Techniques:

Outreach Efforts in ACCELERATE Flowchart from Prescreening of OOC PWH until Study Enrollment. Unreachable: PWH who could not be contacted after sharing study flyer, 4 phone call across 3 weeks, a patient portal message and an email. Out of State: Moved outside Missouri, one of the exclusion criteria of ACCELERATE. Unable to Consent: People who cannot understand and sign the informed consent. Study Drug: Bictegravir/Emtricitabine/Tenofovir Alafenamide

Journal: Open Forum Infectious Diseases

Article Title: P-2071. Reaching the Hard-to-Reach via the ACCELERATE Model of HIV Care: Telehealth, Rapid Restart and Follow-up

doi: 10.1093/ofid/ofaf695.2235

Figure Lengend Snippet: Outreach Efforts in ACCELERATE Flowchart from Prescreening of OOC PWH until Study Enrollment. Unreachable: PWH who could not be contacted after sharing study flyer, 4 phone call across 3 weeks, a patient portal message and an email. Out of State: Moved outside Missouri, one of the exclusion criteria of ACCELERATE. Unable to Consent: People who cannot understand and sign the informed consent. Study Drug: Bictegravir/Emtricitabine/Tenofovir Alafenamide

Article Snippet: We reached 225/464 (49%) PWH, 150/225 (63%) confirmed OOC, 68/150 (45%) were eligible, and 57/68 (84%) were enrolled (Figure 1).

Techniques:

Top 10 Barriers to HIV Care Selected by PWH who were OOC (%, N=43) As part of the baseline survey, respondents chose which barriers were important reasons to fall out of care. For each barrier, the percentage of respondents who identified it as

Journal: Open Forum Infectious Diseases

Article Title: P-2071. Reaching the Hard-to-Reach via the ACCELERATE Model of HIV Care: Telehealth, Rapid Restart and Follow-up

doi: 10.1093/ofid/ofaf695.2235

Figure Lengend Snippet: Top 10 Barriers to HIV Care Selected by PWH who were OOC (%, N=43) As part of the baseline survey, respondents chose which barriers were important reasons to fall out of care. For each barrier, the percentage of respondents who identified it as "important" was calculated. The top 10 barriers were represented by this figure.

Article Snippet: We reached 225/464 (49%) PWH, 150/225 (63%) confirmed OOC, 68/150 (45%) were eligible, and 57/68 (84%) were enrolled (Figure 1).

Techniques: